DFCM
ADVM

Dark Forest Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Dark Forest Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-238
Closed -$4K – 1226
2021
Q4 		$4K Sell
238
-587
-71% -$11.8K ﹤0.01% 1209
2021
Q3 		$18K Buy
+825
New +$21.1K 0.01% 839

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dark Forest Capital Management's ADVM Position: Q1 2022 in Review

Dark Forest Capital Management sold out of Adverum Biotechnologies (ADVM) in Q1 2022, closing a stake of 238 shares — an estimated $4K sold.

Dark Forest Capital Management first reported a position in ADVM in Q3 2021 and held it in 2 quarters. The position peaked at $18K in Q3 2021. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

  • Dark Forest Capital Management reported no remaining Adverum Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 238 Adverum Biotechnologies shares in Q1 2022, an estimated $4K.
  • Dark Forest Capital Management first reported a position in Adverum Biotechnologies in Q3 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's Adverum Biotechnologies position peaked at $18K in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on Dark Forest Capital Management's 13F filing for Q1 2022, filed 13 May 2022.